Search

Your search keyword '"Luc Dupuis"' showing total 162 results

Search Constraints

Start Over You searched for: Author "Luc Dupuis" Remove constraint Author: "Luc Dupuis"
162 results on '"Luc Dupuis"'

Search Results

1. Oligodendrocytes in amyotrophic lateral sclerosis and frontotemporal dementia: the new players on stage

2. Author Correction: Integrative genetic analysis illuminates ALS heritability and identifies risk genes

3. Cystatin C based estimation of chronic kidney disease and amyotrophic lateral sclerosis in the ALS registry Swabia: associated risk and prognostic value

4. Integrative genetic analysis illuminates ALS heritability and identifies risk genes

5. Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriersResearch in context

6. Evaluation of a 5-HT2B receptor agonist in a murine model of amyotrophic lateral sclerosis

7. Morphological alterations of the hypothalamus in idiopathic intracranial hypertension

8. Wild-type FUS corrects ALS-like disease induced by cytoplasmic mutant FUS through autoregulation

9. Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients

10. Cytoplasmic FUS triggers early behavioral alterations linked to cortical neuronal hyperactivity and inhibitory synaptic defects

11. Synaptic FUS accumulation triggers early misregulation of synaptic RNAs in a mouse model of ALS

12. Role of RNA Binding Proteins with prion-like domains in muscle and neuromuscular diseases

13. Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression

15. Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany

16. ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues

17. Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism

18. Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with age

19. Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosiss⃞

20. Antibody-bound β-amyloid precursor protein stimulates the production of tumor necrosis factor-α and monocyte chemoattractant protein-1 by cortical neurons

21. Nogo Provides a Molecular Marker for Diagnosis of Amyotrophic Lateral Sclerosis

22. Differential Screening of Mutated SOD1 Transgenic Mice Reveals Early Up-Regulation of a Fast Axonal Transport Component in Spinal Cord Motor Neurons

23. VAPB/ALS8 MSP ligands regulate striated muscle energy metabolism critical for adult survival in caenorhabditis elegans.

24. Systemic down-regulation of delta-9 desaturase promotes muscle oxidative metabolism and accelerates muscle function recovery following nerve injury.

25. Fumaric acid esters stimulate astrocytic VEGF expression through HIF-1α and Nrf2.

26. Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis.

27. A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis.

28. Platelet serotonin level predicts survival in amyotrophic lateral sclerosis.

29. Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons.

32. Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosis

33. Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers

34. Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients

35. A conditional null allele of Dync1h1 enables targeted analyses of dynein roles in neuronal length sensing and neurological disorders

36. Loss of nucleoporin Nup50 is a risk factor for amyotrophic lateral sclerosis

37. Hypothalamus and weight loss in amyotrophic lateral sclerosis

38. Morphological MRI investigations of the hypothalamus in 232 individuals with Parkinson's disease

39. Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression

40. Synaptic FUS accumulation triggers early misregulation of synaptic RNAs in a mouse model of ALS

41. Dysregulation of energy homeostasis in amyotrophic lateral sclerosis

42. Serotonin and the 5-HT2B Receptor in Amyotrophic Lateral Sclerosis

43. Hypothalamus and weight loss in amyotrophic lateral sclerosis

44. Wild-type FUS corrects ALS-like disease induced by cytoplasmic mutant FUS through autoregulation

45. Orbitofrontal-hypothalamic projections are disrupted in hypermetabolic murine ALS model and human patients

46. Effect of high-caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosis

47. Synaptic accumulation of FUS triggers age-dependent misregulation of inhibitory synapses in ALS-FUS mice

48. Association of Insulin-like Growth Factor 1 Concentrations with Risk for and Prognosis of Amyotrophic Lateral Sclerosis - Results from the ALS Registry Swabia

49. Multiplexed chemogenetics in astrocytes and motoneurons restore blood–spinal cord barrier in ALS

50. Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?© Caroline Moreau et al. 2018; Published by Mary Ann Liebert, Inc. This Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Catalog

Books, media, physical & digital resources